December 23, 2024

A Game-Changer in Male Contraception: Researchers Identify Key Gene

Researchers at Washington State University have discovered a gene called Arrdc5, expressed in the testicular tissue of mice, people, pigs, and cattle, which might result in the development of an extremely effective, reversible, and non-hormonal male contraceptive for both animals and humans. The study found that when the gene was knocked out in mice, it triggered infertility just in males by impacting sperm count, motion, and shape. The protein encoded by this gene is important for regular sperm production, and the team is now dealing with creating a drug to inhibit its production or function. This method prevents hormonal interference, a substantial barrier in male contraception. The genes existence across mammalian types also recommends potential applications in animals and wildlife population management.
Scientists have discovered a gene, Arrdc5, which could lead the way for a reversible, non-hormonal male contraceptive. The gene affects sperm motion, count, and shape, and a drug targeting the genes protein would prevent hormone interference, making it quickly reversible.
The Discovery of a gene in several mammalian species might pave the way for a highly effective, reversible, and non-hormonal male contraceptive for humans and animals.
Washington State University researchers recognized expression of the gene, Arrdc5, in the testicular tissue of mice, pigs, cattle, and people. When they knocked out the gene in mice, it produced infertility only in the males, impacting their sperm movement, shape, and count. The scientists detailed their findings today (April 17) in the journal Nature Communications.

” The study identifies this gene for the first time as being revealed only in testicular tissue, nowhere else in the body, and its revealed by multiple mammalian types,” stated Jon Oatley, senior author and teacher in WSUs School of Molecular Biosciences. “When this gene is inactivated or prevented in males, they make sperm that can not fertilize an egg, and thats a prime target for male contraceptive advancement.”
While other molecular targets have actually been recognized for potential male contraceptive advancement, the Arrdc5 gene is specific to the male testes and found in several types. Importantly, lack of the gene likewise triggers considerable infertility creating a condition called oligoasthenoteratospermia or OAT. This condition, the most typical diagnosis for human male infertility, reveals a decline in the amount of sperm produced, slowed mobility and distorted shape so that the sperm are unable to fuse with an egg.
In the WSU research study, the male mice lacking this gene produced 28% less sperm that moved 2.8 times slower than in typical mice– and about 98% of their sperm had unusual heads and mid-pieces.
The study shows that the protein encoded by this gene is needed for typical sperm production. Oatleys group will next work on creating a drug that would inhibit production or function of that protein.
Disrupting this protein would not need any hormonal disturbance, a key obstacle in male birth control given that testosterone plays other functions beyond sperm production in guys including building bone mass and muscle strength along with red blood cell production. Creating a drug to target this protein would also make it easily reversible as a contraceptive.
” You do not want to erase the ability to ever make sperm– just stop the sperm that are being made from being made properly,” he stated. “Then, in theory, you might eliminate the drug and the sperm would begin being developed usually once again.”
Oatley and research study first author Mariana Giassetti have filed a provisional patent for the development of a male contraceptive based upon this gene and the protein it encodes.
Since the gene is found across mammalian species, this understanding also holds guarantee for usage in animals, Oatley stated. The group analyzed offered biological data on DNA and protein sequences in mammals and found the gene in almost every known mammal types. This opens the potential to develop male birth control for usage in livestock, possibly replacing castration in some instances as a method to control reproduction, and in wildlife when managers seek to limit overpopulation of a types.
The preliminary focus, nevertheless, is on providing human beings more control over their own recreation. While there are numerous forms of contraception for ladies, they are not always effective or widely available, and more than half of pregnancies around the world are still unintended, according to the United Nations.
” Developing a method to suppress population growth and stop unwanted pregnancies is truly important for the future of the human race,” said Oatley. “Right now, we do not actually have anything on the male side for contraception besides surgery and just a little portion of men pick birth controls. If we can establish this discovery into an option for birth control, it could have far-ranging effects.”
Referral: 17 April 2023, Nature Communications.DOI: 10.1038/ s41467-023-37735-y.
This research study received support from the National Institutes of Health and WSUs Functional Genomics Initiative, a multi-year university investment to support development of hereditary technology research study.

Researchers at Washington State University have found a gene called Arrdc5, expressed in the testicular tissue of mice, cattle, people, and pigs, which could lead to the development of a highly effective, reversible, and non-hormonal male contraceptive for both animals and human beings. The study found that when the gene was knocked out in mice, it caused infertility only in males by impacting sperm movement, shape, and count. The protein encoded by this gene is vital for regular sperm production, and the group is now working on creating a drug to hinder its production or function. When they knocked out the gene in mice, it produced infertility just in the males, affecting their sperm motion, count, and shape. While other molecular targets have actually been identified for potential male contraceptive development, the Arrdc5 gene is specific to the male testes and found in numerous types.